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terms of cosmetic results, 99% and 1% of patients considered 
the result as good/excellent and as fair after RT, 
respectively. No patients had a poor cosmetic outcome. 
 
Conclusion: These results support the feasibility and good 
tolerability of SIB-VMAT in elderly patients with a diagnosis of 
breast cancer following CS with acceptable acute and late 
treatment-related toxicity. These preliminary results 
justified continuing the clinical study with the goal to 
establish the impact of hypofractionated SIB-VMAT in elderly 
patients with diagnosis of early stage breast cancer.  
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Purpose or Objective: To investigate the pathogenesis of 
peri-prosthesic capsule contraction (CCPP) related to post 
mastectomy radiotherapy in breast cancer patients 
undergoing breast reconstruction with heterologous material. 
 
Material and Methods: Patients developing (early or late) 
CCPP after breast reconstruction were enrolled in this study. 
CCPP was clinically evaluated by Baker score in order to 
define pain, rigidity, firmness and dislocation of implant. 
CCPP was analysed considering pathological aspect after sub-
total capsulectomy with anterior removal of peri-prosthesic 
capsule. Patients were split into two groups according to 
radiotherapy administration. Group 1 accounted for 
irradiated patients (50 Gy, 2 Gy per fraction on chest wall, 
using tangential field-in-field technique). Group 2 included 
not irradiated patients. Baker Score and microscopic 
observation (simil-synovial reaction, hyalinosis, vascular 
reaction, giant cells) of the two groups were compared by 
univariate and multivariate analysis. 
 
Results: Analysis was performed on 26 patients who 
developed CCPP (29 capsulectomy, because 3 bilateral) in the 
period between April 2012 and February 2015 (34 months). 
All patients developed CCPP within 1 year from first 
reconstructive surgery. Characteristics of both groups are 
reported in Table 1. 
 
Univariate analysis showed a positive association between 
Baker Score and radiotherapy (OR: 1.65), and hyalinosis and 
radiotherapy (OR: 1.2). Multivariate analysis confirmed 
association between CCPP and radiotherapy (OR: 17.9); 
chemotherapy (OR: 4.3) and hormone therapy (OR: 48.44) in 
terms of contraction grade and simil-synovial reactions 
respectively. 
 
Conclusion: Radiotherapy after breast reconstruction 
significantly influenced onset and severity of CCPP, although 
other variables contributed to CCPP multifactorial aetiology. 
In particular, hormone therapy and chemotherapy played a 
role in modifying capsular architecture. 
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Purpose or Objective: Evaluation of radiation- induced 
morbidity is routinely done as an integrated part of 
treatment response follow-up, and can be scored according 
to clinical assessment tools such as the CTCAE or LENT-SOMA. 
Objective measures in this evaluation would be valuable 
given their quantitative nature, facilitating comparison 
across cohorts and treatment institutions. High-frequency 
ultrasound (US) is a high-precision, objective tool to measure 
dermis thickness of the skin. We aimed to analyze dermis 
thickness in a cohort of women following radiotherapy (RT) 
for breast cancer with various grades of induration and 
edema. 
 
Material and Methods: The cohort was recruited from the 
DBCG HYPO/PBI RT protocols and comprised 15 women 
treated for early breast cancer during 2009–2013 with 
lumpectomy and RT 50 or 40 Gy +/- systemic therapy. 
Clinical morbidity follow-up of induration and edema was 
done at baseline and annually according to the LENT-SOMA 
scale. Dermis thickness was measured in mm using high-
frequency US. Points of measurement were 3 cm from the 
areola in four quadrants in both irradiated and contralateral 
non-irradiated breasts. Differences in mean dermis 
thicknesses were tested by two-tailed paired t-test. The US 
scanner utilized was a high-resolution 20 MHz DermaScan® C 
from Cortex Technology ApS. This device is optimized for 
recognizing structures at 60 µm, corresponding to tissue 
microstructures sized like collagenous fibres. 
 
Results: Median follow-up time was 3.0 years (range 1.0 – 
4.6). Overall, mean dermis thicknesses were 2.22 mm (1.78 -
2.66) in the irradiated (I) breast and 1.26 mm (95% CI: 1.08 - 
1.44) in the contralateral (C) breast. Mean difference 
between breasts was 0.96 mm (0.49 - 1.43, p<0.001). Dermis 
thickness was distributed in quadrants as follows: Lower 
lateral I: 2.62 (1.92 – 3.31) C: 1.11 (0.96 - 1.26), lower 
medial I: 2.64 (2.06 – 3.21) C: 1.45 (1.18 - 1.72), upper 
lateral I: 1.55 (1.33 – 1.78) C: 1.17 (1.01 – 1.34), upper 
medial I: 2.08 (1.49 – 2.67) C: 1.31 (1.09 – 1.53). In patients 
without clinical edema, the mean difference in dermis 
thickness for grade 1 induration was 0.35 mm (-0.46 - 1.16, 
p=0.21) and for grade 2 induration 0.71 mm (-0.01 - 1.43, 
p>0.05). In patients with clinical edema, only one patient had 
grade 1 induration (dermis thickness difference 1.34 mm). In 
